Wallonia-BIOMED — HuMAb-S aureus — CER (Q4027002)

From EU Knowledge Graph
Revision as of 09:51, 18 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in de, and other parts: Adding German translations)
Jump to navigation Jump to search
Project Q4027002 in Belgium
Language Label Description Also known as
English
Wallonia-BIOMED — HuMAb-S aureus — CER
Project Q4027002 in Belgium

    Statements

    0 references
    615,451.18 Euro
    0 references
    1,538,627.94 Euro
    0 references
    40.0 percent
    0 references
    15 May 2014
    0 references
    31 December 2023
    0 references
    CER-Groupe
    0 references
    0 references
    0 references

    50°11'10.64"N, 5°17'59.03"E
    0 references
    6900
    0 references
    Développement d'un projet de recherche dans le domaine des anticorps monoclonaux humains à but thérapeutique utilisant le S.aureus comme modèle. (French)
    0 references
    Development of a research project in the field of therapeutic human monoclonal antibodies using S.aureus as a model. (English)
    17 January 2022
    0 references
    Ontwikkeling van een onderzoeksproject op het gebied van therapeutische menselijke monoklonale antilichamen die S.aureus als model gebruiken. (Dutch)
    18 January 2022
    0 references
    Entwicklung eines Forschungsprojekts auf dem Gebiet therapeutischer humaner monoklonaler Antikörper mit S.aureus als Modell. (German)
    18 January 2022
    0 references

    Identifiers

    WAL-874
    0 references